Cargando…
Molnupiravir’s mechanism of action drives “error catastrophe” in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virus
Autores principales: | Chatterjee, Srijan, Bhattacharya, Manojit, Dhama, Kuldeep, Lee, Sang-Soo, Chakraborty, Chiranjib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300273/ https://www.ncbi.nlm.nih.gov/pubmed/37397276 http://dx.doi.org/10.1016/j.omtn.2023.06.006 |
Ejemplares similares
-
Can the RBD mutation R346X provide an additional fitness to the “variant soup,” including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance?
por: Chatterjee, Srijan, et al.
Publicado: (2023) -
Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
por: Chatterjee, Srijan, et al.
Publicado: (2023) -
Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole genome encoded proteins: An immunoinformatics approach
por: Bhattacharya, Manojit, et al.
Publicado: (2022) -
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
por: Chatterjee, Srijan, et al.
Publicado: (2023) -
The D614G mutation helps to increase the transmissibility and reduce the virulence of SARS-CoV-2 variants through natural selection
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)